Friday, April 10, 2009
Scar-Reducing Drug Shows Promise
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
A drug designed to reduce scarring after surgery or injury has shown promising results in early human trials, UK researchers say.
In this blog I want to tell the story of the pharmaceutical world. I will not just through my post, but also pointing out the major news affecting the industry and especially with the help of the many posts that I send
Blog Archive
-
▼
2009
(46)
-
▼
April
(45)
-
▼
Apr 10
(17)
- Amgen Cuts 100 Jobs at Washington Manufacturing Plant
- Scar-Reducing Drug Shows Promise
- Study links the Pill to increased lupus risk
- Pharmaceuticals Provide a Takeover Tonic
- FDA Rebuffs Teva’s Citizen Petition on Generic Cop...
- Supreme Court Asked to Review Prescriber Data Case
- FDA Reverses Course, Drugmakers Allowed to Make Mo...
- Medtronic Wraps Up Buy of CoreValve
- Panel Rejects Stryker OP-1 Bone Putty for PMA Appr...
- Minimally Invasive Technologies Expected to Be Boo...
- Crofelemer, First-in-Class Anti-Diarrheal Agent, P...
- J&J Cutting About 900 Jobs From Pharma Unit
- Pfizer's Oncology Business Unit Appoints Vice Pres...
- the Impact of the Withdrawal of Raptiva (efalizuma...
- New drug shows promise in treating drug-resistant ...
- 'Unapproved' morphine to stay on market, FDA rules
- Test quickly assesses whether Alzheimer's drugs ar...
-
▼
Apr 10
(17)
-
▼
April
(45)
No comments:
Post a Comment